Increased risk of infections in smoldering multiple myeloma: Results from the screened iStopMM study
Infections are a well-recognized threat in multiple myeloma – but what about its precursor smoldering multiple myeloma (SMM)? Our study sheds light on infection risk in SMM, uncovering hidden vulnerabilities and offering new insight into this asymptomatic condition.
Decoding the Hidden Microbiome Behind Triple-Negative Breast Cancer
Our study provides the first comprehensive meta-analysis of the breast tissue microbiome in triple-negative breast cancer. By uncovering distinct microbial players, we highlight how these microbes may fuel cancer aggressiveness and open the door to microbiome-based therapies
When cancer cells get squeezed: discovering how physical forces shape metastasis
Cancer’s deadliest trait is its spread. Millions of tumor cells enter the bloodstream daily, yet only a few survive and seed metastases. Why these rare cells succeed, while most perish, remains one of cancer research’s greatest mysteries.
Unanswered Questions: AML with IDH Mutations
The optimal induction regimen for intensive chemotherapy-eligible patients with IDH-mutated AML has not been established. In our recently published study, we report outcomes of newly diagnosed IDH-mutated AML treated with intensive chemotherapy plus venetoclax, highlighting efficacy and challenges.
A Genomic Wake-Up Call: Rethinking Breast Cancer Through the African Lens
In our recent NPJ Breast Cancer study, we reviewed all available data on breast cancer mutations in African populations—revealing distinct genetic patterns and major gaps in current knowledge.
